Skip to content

Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506633-30-00
Enrollment
12
Registered
2023-10-12
Start date
2023-10-13
Completion date
2023-12-21
Last updated
2023-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A submitted trial is conducted on healthy subjects

Interventions

None listed

Sponsors

Pikralida Sp. z o.o.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Czechia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026